Nonfasting Apo-lipoprotein B and triglyceride levels as a predictor of coronary heart disease in type II diabetic patients

ABSTRACT

Background and Objectives: Lipoprotein-A has been recognized as a risk factor for ischemic heart diseases. Myocardial infarction [MI] is common complication of ischemic heart disease. Diabetes play an incremental role in the development of coronary artery disease [CAD], however still there are conflicting data regarding the relationship of Lipoprotein-B and MI. We therefore wanted to evaluate the relationship of Lipo-B, MI and diabetes mellitus. Our objective was to determine the non-fasting Apo-lipoprotein B and triglycerides level among type II diabetic patients with ischemic heart disease and to compare with type II diabetic without ischemic heart disease